Abstract
Cancer is a devastating pathology that involves symptoms, discomfort, family and social disintegration, and finally leads to a debilitating condition and death. It was Otto Warburg, the extraordinary German scientist, who opened our eyes towards the notion of the existence of a metabolic disruption in cancer cells. Since Warburg pioneering studies physicians and scientists had considered a role of mitochondria in the genesis of cancer. Mitochondria are ancient rickettsia incorporated as organelles into a primitive eukaryotic recipient cell. Mitochondria changed the primitive anaerobic metabolism to an oxygen dependent respiration that multiplied the energy production in cells from 2 to 36 moles of ATP by mol of utilized glucose. Therefore, this chapter is mainly directed to respond what happens to mitochondria in cancer. We will describe here the mitochondrial alterations reported in this pathology. The reader will realize that we favor the notion that mitochondrial dysfunction and the incorrect use of oxygen are factors associated to a particular cell development and function that at the same time is the mechanism of pathogenesis of a debilitating and mortal illness.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Klaunig JE, Kamendulis LM, Hocevar BA (2010) Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol 38:96–109
Koppenol WH, Bounds PL, Dang CV (2011) Otto Warburg’s contributions to current concepts of cancer metabolism. Nature Review Cancer 11:325–337
Shen HM, Ong CN (1996) Mutation of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis. Mutat Res 366:23–44
Fraga CG, Shigenaga MK, Park J-W et al (1990) Oxidative damage to DNA during aging: 8-hydroxy-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci U S A 87:4533–4537
Lu J, Tan M, Cai Q (2015) The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism. Cancer Lett 356:156–164
Nunomura W, Takakuwa Y, Cherr GN et al (2007) Characterization of protein 4.1R in the erythrocytes of zebrafish (Danio rerio): unique binding properties with transmembrane proteins and calmodulin. Comp Biochem Physiol B Biochem Mol Biol 148:124–138
Uchida HK, Szweda I, Chae Z et al (1993) Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc Natl Acad Sci U S A 90:8742–8746
Nishigori C, Hattori Y, Toyokuni S (2004) Role of reactive oxygen species in skin carcinogenesis. Antioxid Redox Signal 6:561–570
Weiss KM (2005) The phenogenetic logic of life. Nat Rev Genet 6:36–45
Miyake T, Reese J, Loch CM et al (2004) Genome-wide analysis of ARS (autonomously replicating sequence) binding factor 1 (Abf1p)-mediated transcriptional regulation in Saccharomyces cerevisiae. J Biol Chem 279:34865–34872
Syslová K, Böhmová A, Mikoška M et al (2014) Multimarker screening of oxidative stress in aging. Oxid Med Cell Longev 2014:562860. doi:10.1155/2014/562860
Hwang ES, Bowen PE (2007) DNA damage, a biomarker of carcinogenesis: its measurement and modulation by diet and environment. Crit Rev Food Sci Nutr 47:27–50
Frenkel K (1992) Carcinogen-mediated oxidant formation and oxidative DNA damage. Pharmac Ther 53:127–166
Demple B, Harrison L (1994) Repair of oxidative damage to DNA: enzymology and biology. Annu Rev Biochem 63:915–948
Shibutani S, Takeshita M, Grollman AP (1991) Insertion of specific bases during DNA synthesis past the oxidation damaged base 8-oxodG. Nature 349:431–444
Gredilla R, Bohr VA, Stevnsner T (2010) Mitochondrial DNA repair and association with aging: an update. Exp Gerontol 45:478–488
Gao Y, Dickerson JB, Guo F et al (2004) Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci U S A 101:7618–7623
Kawanishi S, Hiraku Y (2006) Oxidative and nitrative DNA damage as biomarker for carcinogenesis with special reference to inflammation. Antioxid Redox Signal 8:1047–1058
Evans MD, Dizdaroglu M, Cooke M (2004) Oxidative DNA damage and disease: induction, repair and significance. Mutat Res 567:1–61
Liu RH (2004) Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr 134:3479S–3485S
Ishikawa K, Takenaga K, Akimoto M et al (2008) ROS generating mitochondrial DNA mutations regulate tumor cell metastasis. Science 320:661–664
Frank GD, Mifune M, Inagami T et al (2003) Distinct mechanisms of receptor and nonreceptor tyrosine kinase activation by reactive oxygen species in vascular smooth muscle cells: role of metalloprotease and protein kinase C-delta. Mol Cell Biol 235:1581–1589
Lin D, Takemoto DJ (2005) Oxidative activation of protein kinase C gamma through the C1 domain. Effects on gap junctions. J Biol Chem 280:13682–13693
Gopalakrishna R, Anderson WB (1989) Ca2+ and phospholipid independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc Natl Acad Sci 86:6758–6762
Kensler TW, Wakabayashi N, Biswal S (2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47:89–116
Benhar M, Engelberg D, Levitzki A (2002) ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep 3:420–425
Rankin EB, Giaccia AJ (2008) The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 15:678–685
Warburg O (1956) On the origin of cancer cells. Science 123:309–314
Arner ES, Holmgren A (2000) Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 267:6102–6109
Dunbar DR, Moonie PA, Jacobs HT et al (1995) Different cellular back-grounds confer a marked advantage to either mutant or wild-type mitochondrial genomes. Proc Natl Acad Sci U S A 92:6562–6566
Nishikawa M, Nishiguchi S, Shiomi S et al (2001) Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma. Cancer Res 61:1843–1845
Lievre A, Blons H, Houllier AM et al (2006) Clinicopathological significance of mitochondrial D-Loop mutations in head and neck carcinoma. Br J Cancer 94:692–697
Prior SL, Griffiths AP, Baxter JM et al (2006) Mitochondrial DNA mutations in oral squamous cell carcinoma. Carcinogenesis 27:945–950
He Y, Wu J, Dressman DC et al (2010) Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. Nature 464:610–614
Coller HA, Khrapko K, Bodyak ND et al (2001) High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat Genet 28:147–150
Chatterjee A, Dasgupta S, Sidransky D (2011) Mitochondrial subversion in cancer. Cancer Prev Res (Phila) 4:638–654
Wheelhouse NM, Lai PB, Wigmore SJ et al (2005) Mitochondrial D-loop mutations and deletion profiles of cancerous and noncancerous liver tissue in hepatitis B virus-infected liver. Br J Cancer 92:1268–1272
Gochhait S, Bhatt A, Sharma S et al (2008) Concomitant presence of mutations in mitochondrial genome and p53 in cancer development: a study in north India sporadic breast and esophageal cancer patients. Int J Cancer 123:2580–2586
Carew JS, Zhou Y, Albitar M et al (2003) Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications. Leukemia 17:1437–1447
Maitra A, Cohen Y, Gillespie SE et al (2004) The Human MitoChip: a high-throughput sequencing nicroarray for mitochondrial mutation detection. Genome Res 14:812–819
Hung WY, Lin JC, Lee LM et al (2008) Tandem duplication- triplication correlated with poly-cytosine stretch variation in human mitochondrial DNA D-loop region. Mutagenesis 23:137–142
Sanchez-Pino MJ, Moreno P, Navarro A (2007) Mitochondrial dysfunction in human colorectal cancer progression. Front Biosci 12:1190–1199
Sanchez-Cespedes M, Parrella P, Nomoto S et al (2001) Identification of a nucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res 61:7015–7019
Galli S, Labato MI, Bal de Kier JE et al (2003) Decreased mitochondrial nitric oxide activity and hydrogen peroxide relate persistent tumoral proliferation to embryonic behavior. Cancer Res 63:6370–6377
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Poderoso, J.J. (2016). Cancer and Mitochondria. In: Gelpi, R., Boveris, A., Poderoso, J. (eds) Biochemistry of Oxidative Stress. Advances in Biochemistry in Health and Disease, vol 16. Springer, Cham. https://doi.org/10.1007/978-3-319-45865-6_26
Download citation
DOI: https://doi.org/10.1007/978-3-319-45865-6_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-45864-9
Online ISBN: 978-3-319-45865-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)